|
1) Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution Circulation. 2007; 115: 163-72
|
|
|
|
2) Marelli AJ, Therrien J, Mackie AS, et al. Planning the specialized care of adult congenital heart disease patients: from numbers to guidelines; an epidemiologic approach. Am Heart J. 2009; 157: 1-8
|
|
|
|
|
3) Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001; 37: 1170-5
|
|
|
|
|
|
4) Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005; 26: 2325-33
|
|
|
|
|
|
5) Wacker A, Kaemmerer H, Hollweck R, et al. Outcome of operated and unoperated adults with congenital heart disease lost to follow-up for more than 5 years. Am J Cardiol. 2005; 95: 776-9
|
|
|
|
|
|
6) Niwa K, Perloff JK, Webb GD, et al. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol. 2004; 96: 211-6
|
|
|
|
|
|
7) Webb GD, Williams RG. 32nd Bethesda Conference: “Care of the adult with congenital heart disease". J Am Coll Cardiol. 2001; 37: 1161-98
|
|
|
|
|
|
8) Perloff JK, Warnes CA. Congneital heart disease in adults: a new cardiovascular specialty. Circulation. 2001; 84: 1881-90
|
|
|
|
|
|
9) van Rijen EH, Utens EM, Roos-Hesselink JW, et al. Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J. 2004; 25: 1605-13
|
|
|
|
|
|
10) 丹羽公一郎. 診療体制. In: 丹羽公一郎, 中澤 誠, 編. 成人先天性心疾患. 新目で見る循環器病シリーズ 14. 東京: メジカルビュー社; 2005. p. 235-41
|
|
|
|
|
|
11) Moons P, Van Deyk K, Marquet K, et al. Individual quality of life in adults with congenital heart disease: a paradigm shift. Eur Heart J. 2005; 26: 298-307
|
|
|
|
|
|
12) Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008; 52: e1-121, Circulation. 2008; 118: e714-833. http://circ.ahajournals.org/cgi/content/full/118/23/e714
|
|
|
|
|
|
13) Gatzoulis MA. Adult congenital heart disease: a cardiovascular area of growth in urgent need of additional resource allocation. Int J Cardiol. 2004; 97 Suppl 1: 1-2
|
|
|
|
|
|
14) Perloff JK, Somerville J, Webb GD, et al. Medical center experiences. J Am Coll Cardiol. 1991; 18: 311-8
|
|
|
|
|
|
15) Therrien J, Dore A, Gersony W, et al. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Can Cardiol. 2001; 17: 940-59
|
|
|
|
|
|
16) 門間和夫, 石澤 瞭, 加藤裕久, 他. 成人先天性心疾患診療ガイドライン. Jpn Circ J. 2000; 64 Supple IV: 1167-204, J Cardiol. 2002; 40: 65-78
|
|
|
|
|
|
17) 黒澤博身, 赤木禎治, 石澤 瞭, 他, 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). 成人先天性心疾患診療ガイドライン(2006年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2006_kurosawa_h.pdf
|
|
|
|
|
|
18) Deanfield J, Thaulow E, Warnes C, et al. Management of grown up congenital heart disease. The task force on the management of grown up congenital heart disease of the European Society of Cardiology. Eur Heart J. 2003; 24: 1035-84
|
|
|
|
|
|
19) Wren C, O'Sullivan JJ. Future demand for follow-up of adult survivors of congenital heart disease. Heart. 2001; 85: 438-43
|
|
|
|
|
|
20) Shiina Y, Toyoda T, Kawasoe Y, et al. Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol. 2009 Jun 1. [Epub ahead of print]
|
|
|
|
|
|
21) Niwa K, Tateno S. Kawasaki's disease. In: Gatzoulis MA, Webb GD, Daubeney PEF. Editors. Diagnosis and Management of Adult Congenital Heart Disease. Edinburgh: UK; 2003. p. 433-9
|
|
|
|
|
|
22) Reid GJ, Irvine MJ, McCrindle BW, et al. Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects. Pediatrics. 2004; 113: e197-205
|
|
|
|
|
|
23) Graham J. Reid, M. Irvine J, et al. Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects. Pediatrics. 2004; 113; e197-205
|
|
|
|
|
|
24) Wilson W, Taubert KA, Gewitz M, et al, Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation. 2007; 116: 1736-54
|
|
|
|
|
|
25) Niwa K, Nakazawa M, Tateno S, et al. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart. 2005; 91: 795-800
|
|
|
|
|
|
26) 宮武邦夫, 赤石 誠, 石塚尚子, 他. 循環器病の診断と治療に関するガイドライン(2007年度合同研究班報告). 感染性心内膜炎の予防と治療に関するガイドライン(2007年改訂版). 日循. http://www.j-circ.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf
|
|
|
|
|
|
27) Schaefer C, Hannemann D, Meister R, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006; 95: 949-57
|
|
|
|
|
|
28) Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006; 354: 2443-51
|
|
|
|
|
|
29) Kaemmerer H, Bauer U, Pensl U, et al. Management of emergencies in adults with congenital cardiac disease. Am J Cardiol. 2008; 101: 521-5
|
|
|
|
|
|
30) Epstein AE, Di Marco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnomalities. J Am Coll Cardiol. 2008; 51: e1-62
|
|
|
|
|
|
31) Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008; 117: 363-70
|
|
|
|
|
|
32) Yap SC, Roos-Hesselink JW, Hoendermis ES, et al. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur Heart J. 2007; 28: 1854-61
|
|
|
|
|
|
33) Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002; 106: 92-9
|
|
|
|
|
|
34) Ohuchi H, Takasugi H, Ohashi H, et al. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients. Circulation. 2004; 110: 2601-8
|
|
|
|
|
|
35) Hopkins WE, Chen Z, Fukagawa NK, et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation. 2004; 109: 2872-7
|
|
|
|
|
|
36) Davlouros PA, Niwa K, Webb G, et al. The right ventricle in congenital heart disease. Heart. 2006; 92: 27-38
|
|
|
|
|
|
37) Janousek J, Tomek V, Chaloupecky VA, et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol. 2004; 44: 1927-31
|
|
|
|
|
|
38) Thambo JB, Bordachar P, Garrigue S, et al. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation. 2004; 110: 3766-72
|
|
|
|
|